Summary:
To address drug shortages and concerns about quality, industry experts say Congress should consider steps such as improving hospital incentives and revising purchasing contracts.
Mounting drug shortages and supply chain vulnerabilities are putting patient care at risk in hospitals across the nation. As experts sound the alarm in Congress, questions grow about the safety, cost, and reliability of vital medicines. What concrete steps can policymakers and industry leaders take to secure America’s pharmaceutical future? Read on to discover the proposals and debates shaping the path forward.
Source: Senate Committee Examines Ways to Strengthen the Supply Chain for Hospital Drugs, Nick Hut, HFMA, October 13,2025; https://www.hfma.org/operations-management/senate-committee-examines-ways-to-strengthen-the-supply-chain-for-hospital-drugs/ .
Topics
Quality Improvement
Healthcare Process
Environmental Influences
Related
Healthcare Insights: Curated for HALM November/December 2025Physicians Can Play a Role in the Safety of Patients Considering Treatments AbroadIs This a Moment for Strategic Hibernation?Recommended Reading
Strategy and Innovation
Healthcare Insights: Curated for HALM November/December 2025
Strategy and Innovation
Physicians Can Play a Role in the Safety of Patients Considering Treatments Abroad
Strategy and Innovation
Is This a Moment for Strategic Hibernation?
Quality and Risk
Navigating the Physician Journey Across the Domains of Health Policy: Learning, Contributing, and Leading
Quality and Risk
Why Brittle Bones Aren’t Just a Woman’s Problem